Weight Loss Medication on the Horizon?
Obesity one of the most important public health problems, today, with an estimated 65% of all US adults either overweight or obese. 112,000 to 280,000 deaths per year are attributed to complications due to obesity.
A new drug by the name of Acomplia may be on the horizon. Hear the results of the latest study using this new class of drug that blocks the endocannabinoid recepters.
Click here to read Effect of Rimonabant
Medline conference on rimonabant. To view, you must register for Medline, which is free.
http://www.medscape.com/viewprogram/3779
Listen here.
A new drug by the name of Acomplia may be on the horizon. Hear the results of the latest study using this new class of drug that blocks the endocannabinoid recepters.
Click here to read Effect of Rimonabant
Medline conference on rimonabant. To view, you must register for Medline, which is free.
http://www.medscape.com/viewprogram/3779
Listen here.
posted by Margie Geiser, MBA, RD, NSCA-CPT at
4:14 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home